Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy (Q43702187)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy |
scientific article |
Statements
1 reference
Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy (English)
1 reference
Kwan Sik Lee
1 reference
Kwan Soo Byun
1 reference
Young-Hwa Chung
1 reference
Seung Woon Paik
1 reference
Joon-Yeol Han
1 reference
Kwon Yoo
1 reference
Hee-Won Yoo
1 reference
Byung Chul Yoo
1 reference
Hyo-Suk Lee
1 reference
9 July 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference